What is the dosage and usage of Diltiazem (calcium channel blocker) for treating hypertension, angina, and heart rhythm disorders?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diltiazem Dosing for Hypertension, Angina, and Heart Rhythm Disorders

Diltiazem should be dosed at 120-360 mg daily for hypertension (typically requiring higher doses up to 360 mg), 120-240 mg daily for angina, and 0.25 mg/kg IV (approximately 15-20 mg) over 2 minutes for acute supraventricular tachycardia. 1, 2

Indications

  • FDA-approved for management of chronic stable angina and angina due to coronary artery spasm 3
  • Effective for hypertension, requiring higher doses (typically 360 mg daily) than for angina (typically 240 mg daily) 2, 4
  • Second-line agent for paroxysmal supraventricular tachycardia (PSVT) when adenosine fails or is contraindicated 1

Dosing Guidelines

For Hypertension:

  • Initial dose: 120 mg daily in divided doses or as single dose with long-acting formulations 2
  • Maintenance dose: Up to 360 mg daily 2
  • Dose-response relationship is linear through 480-540 mg/day range for blood pressure lowering 4
  • Often underdosed in clinical practice (90-120 mg/day is considered a "no-effect dose" for hypertension) 4

For Angina:

  • Initial dose: 120 mg daily in divided doses 2, 5
  • Maintenance dose: Typically 240 mg daily, though some patients may require up to 360 mg daily 2, 5
  • May be used as monotherapy or in combination with nitrates for severe angina 5

For Supraventricular Tachycardia:

  • IV bolus: 0.25 mg/kg (approximately 15-20 mg for average adult) administered over 2 minutes 1
  • If hypotension is a concern, a slow infusion of 2.5 mg/min for up to 20 minutes may reduce this risk 6

Contraindications and Precautions

  • Avoid in patients with: 1, 2, 3

    • AV block greater than first degree (without pacemaker)
    • Sick sinus syndrome
    • Hypotension
    • Decompensated systolic heart failure or severe LV dysfunction
    • Pre-excited atrial fibrillation/flutter (WPW syndrome)
  • Use with caution when combined with: 6, 2, 3

    • Beta-blockers (risk of significant bradyarrhythmias and heart failure)
    • Digitalis (additive effects on cardiac conduction)
    • Medications metabolized by CYP3A4 (diltiazem is a moderate CYP3A4 inhibitor)

Adverse Effects

  • Hypotension is the most common adverse effect 1, 2, 3
  • Bradycardia may occur, particularly with concomitant use of other negative chronotropic agents 1, 3
  • Worsening heart failure in predisposed patients 1, 3
  • Pedal edema, especially with higher doses 5
  • Rare instances of significant elevations in liver enzymes 3

Monitoring

  • Blood pressure and heart rate 2
  • Signs and symptoms of heart failure in at-risk patients 2
  • ECG monitoring in patients with conduction system disease 2
  • Liver function tests if clinically indicated 2

Clinical Pearls

  • For hypertension in patients with coronary artery disease, if beta-blockers are contraindicated, diltiazem may be substituted, but not if there is LV dysfunction 6
  • When diltiazem is used for hypertension with stable angina, it can be combined with an ACE inhibitor/ARB and thiazide diuretic if needed for BP control 6
  • Resuscitation equipment should be available when administering IV diltiazem 1
  • For severe bradycardia as a side effect, consider atropine or temporary pacing if needed 1

References

Guideline

Diltiazem Dosing for Paroxysmal Supraventricular Tachycardia (PSVT)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diltiazem Dosing and Management for Hypertension and Angina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anomalies in the dosing of diltiazem.

Clinical cardiology, 2000

Research

Effectiveness of diltiazem for chronic stable angina pectoris.

Acta pharmacologica et toxicologica, 1985

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.